tag anxiety-disorders 
pharmaphorum
JANUARY 11, 2022
The DTx, called BNT200, is described as a first-of-its-kind DTx to treat anxiety and depression in adults with acute myeloid leukaemia (AML) who are hospitalised for a regimen of high-intensity induction chemotherapy. The post Blue Note leukaemia DTx gets FDA breakthrough tag appeared first on.
Rethinking Clinical Trials
OCTOBER 19, 2022
substance use, depression, anxiety, suicidality). Trials are getting larger and collecting greater volumes of clinical data than ever before, often as part of Common Data Elements (CDEs). These data increasingly include info that might signal physical, mental health or behavioral health risks to patient-subjects (e.g. pctGR, @Collaboratory1.
Expert insights. Personalized for you.
64 
Let's personalize your content